Along with several other drugmakers, Novartis has bet that lowering Lp(a) will cut the risk of sometimes fatal cardiovascular events.
Similar stories
2 outlets
See how this story developed, hour by hour
Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%
finance.yahoo.com
08.09.2026
Why Novartis’ Drug Trial Results Are Blowing Up Amgen Stock
barrons.com
08.09.2026
Related stories
Walmart, Best Buy and other stores now use digital price tags. Critics say they could lead to different prices for different shoppers.
Retire on 8% a year with little or no risk? How to use annuities the right way.
The little-known investment Martin Lewis wants you to understand...
Civil servant who juggled five jobs says he was 'surprised' to be charged with fraud
Everyone’s talking about Roth conversions, but here’s how few people really do them — and why you shouldn’t have FOMO about it
Gold drops below $4,000 as ‘haven’ asset joins market sell-off